Concentrix (CNXC)
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-07-23
Reading CNXC? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-07-23
Reading CNXC? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround opportunity. CNXC is currently loss-making with weak recent performance, but it is priced cheaply compared to its peers, indicating some market skepticism.
The market seems to have priced in a low growth outlook, as reflected in the valuation being cheap versus peers. The expectations gap suggests that investors are not anticipating significant improvements in performance in the near term.
Management has set ambitious revenue and free cash flow targets for fiscal 2026, with some progress noted in recent quarters. However, the company's recent financial performance has been weak, which adds uncertainty to achieving these goals.
The future performance of CNXC will depend on its ability to meet management's revenue and cash flow targets. Additionally, the performance of sector bellwethers like BR, LDOS, and CACI will be crucial, as their results could influence investor sentiment and expectations for CNXC.
In the next 1 to 3 years, CNXC's success will hinge on its execution of financial targets and the broader industrial sector's performance. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The company trimmed its 2026 revenue outlook, impacting growth expectations. Recent financial performance remains weak, which raises market concerns. The stock dropped significantly despite sales being in line with estimates.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Meeting or exceeding this guidance shows Concentrix is on track for its full-year revenue target.
Confirms:Q3 revenue reported at $2.465 billion or higher.
Disproves:Q3 revenue reported below $2.465 billion.
Why it matters: Falling short of this target would signal ongoing cash flow issues and limit growth investments.
Confirms:Adjusted free cash flow reported below $630 million.
Disproves:Adjusted free cash flow meets or exceeds $630 million.
Why it matters: Reaching this EPS target means the company makes good money. It runs well.
Confirms:Non-GAAP diluted EPS of $2.65 or higher in Q3.
Disproves:Non-GAAP diluted EPS falls below $2.65 in Q3.
Why it matters: Meeting this target shows strong cash flow and good use of capital.
Confirms:Adjusted free cash flow reported between $630 million and $650 million.
Disproves:Adjusted free cash flow reported below $630 million.
Why it matters: This range shows Concentrix is keeping profits up during tough times.
Confirms:Non-GAAP diluted EPS was between $11.48 and $12.07.
Disproves:Non-GAAP diluted EPS was below $11.48.
Why it matters: Continued growth in iX Suite deals shows Concentrix's strength in AI-driven solutions.
Confirms:iX Suite deals reported to grow year over year by 400% or more.
Disproves:iX Suite deals reported to grow less than 400% year over year.